Researchers at City of Hope found that taking white button mushroom pills reduces a class of immune cells called myeloid-derived suppressor cells, which has been linked to cancer development and spread.
Hodgkin lymphoma has long been a model disease in the field of oncology—one of the first diseases we learned to cure with radiation and ultimately chemotherapy.
The Longevity Consortium received a five-year, $45 million grant to move the consortium’s work to its next stage: integrating results from numerous studies about the factors that contribute to longer and healthier lives.
Robert R. Jenq was named director of the microbiome program at City of Hope and clinical professor in the Department of Hematology and Hematopoietic Cell Transplantation.
City of Hope has received a $150 million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand to create a program focused on pancreatic cancer research.
Alessio Pigazzi named executive medical director of colorectal surgery at City of Hope Orange County
Alessio Pigazzi was appointed executive medical director of colorectal surgery at City of Hope Orange County.
The Translational Genomics Research Institute, part of City of Hope, announced the opening of the Center for Spatial Multi-Omics, a service center dedicated to transforming biomedical research through spatial biology.
Simon Nazarian was named executive vice president and chief digital and technology officer at City of Hope. He will join the institution on Sept. 9.
City of Hope and Charles R. Drew University of Medicine and Science, the only Historically Black Graduate Institution west of the Mississippi River and one of only four Historically Black Medical Schools, announced the launch of a new partnership to educate a more diverse workforce in specialized medicine through internships, curriculum, training, mentorships, joint research projects, and more.
A pioneering phase I CAR T-cell therapy trial for the treatment of glioblastoma at City of Hope, demonstrates promising clinical activity against incurable brain tumors, according to research published in Nature Medicine.
